Tag: Drug Marking

Over 10,000 Russian pharma market participants joined the labeling system

marking
According to the head of Roszdravnadzor, about 10,000 of pharma market participants across the country have joined the program for monitoring of preparedness for the project on the labeling of drugs.

Recipharm released the first EU FMD compliant products to Europe

drug-serialization
Recipharm, a leading contract development and manufacturing organisation (CDMO), has released its first serialised products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden.

Recipharm receives EMVO approval

recipharm
Recipharm, a leading contract development and manufacturing organisation has received European Medicines Verification Organisation (EMVO) approval to submit serialisation data to the European Hub.

SID&GP presented results of manufacturers survey

marking
Vladislav Shestakov took part in the meeting dedicated to labeling of pharmaceutical products where he discussed prospects of pharmaceutical labeling.

Russian government extended drug labeling pilot project until the end of 2019

drug-marking
Russian Prime Minister, Dmitry Medvedev, signed resolution, according to which in order to provide information and technical support to the priority drug labeling project .

Schreiner MediPharm created Covert-Hologram Seal for tamper protection

drug-marking
Schreiner MediPharm has developed a multifunctional Covert-Hologram Seal that offers reliable first-opening indication and tamper evidence, plus counterfeiting protection.

TraceLink rolls out its Russian serialization solution

trackandtrace
TraceLink announced its Russian compliance solution, providing companies with the ability to meet requirements for serialization, traceability, and compliance reporting for all pharmaceutical manufacturers.

Wasdell Group started serialization service

marking
The Wasdell Group, a leading partner to companies within the pharmaceutical, medical device and clinical trials industries, has launched its serialisation service ahead of the EU FMD and US DSCSA implementation deadlines.

Four more pharma manufacturers will receive loans to buy labeling equipment

ozon-pharm
IDF programs allow Russian companies to access preferential loan financing required for launching the manufacturing of unique local products, as well as the analogs of advanced international products.

Recipharm starts its standalone serialisation service

recipharm
Recipharm, a leading contract development and manufacturing organisation (CDMO) has announced the launch of its standalone serialisation service ahead of the introduction of the EU Falsified Medicines Directive (FMD).

IBI Lorenzini will use TraceLink’s serialization solutions

marking
TraceLink, the world’s largest track and trace network, announced that IBI Lorenzini has selected TraceLink’s solutions to ensure compliance with global serialization regulations.

The cost of drug labeling implementation is considered as reasonable

drug-marking
According to market participants, the costs of drug manufacturers on mandatory implementation of labeling by 2020 will not increase the cost of drugs.

Takeda produced three pilot batches of Actovegin as part of drug labeling project

takeda
Three pilot batches of Actovegin in the total amount of more than 40 thousand packages were produced under the drug labeling project involving the application of special 2D code.

IDF approved the first loan under Drug Labeling program

The Expert Council of the Industrial Development Fund (IDF) has approved the first loan under the Drug Labeling program. The loan was provided to Polysan Scientific & Technological Pharmaceutical Company from St. Petersburg.

Russian government approved operation model for product labeling system

marking
Prime Minister of the Russian Federation signed the Order No. 791-r of April 28, 2018, which approved the operation model for the system of labeling products by means of identification in the Russian Federation.

Loans to purchase drug labeling equipment are available at 1% per annum

idf
Industrial Development Fund (IDF) launched a new preferential lending program for the purchase of drug labeling equipment. The key feature of the program is that the company is not required to co-finance the project.